Health Care Factors Related to Stage at Diagnosis and Survival Among Medicare Patients With Colorectal Cancer
Datos Bibliográficos
| ID | 9103816 |
|---|---|
| Autores | Anna Lee-Feldstein, Anna Lee‐Feldstein (autor de correspondencia), Paul J Feldstein (University of California, Irvine), Thomas C Buchmueller (0000-0002-3068-7419, University of California, Irvine), Thomas Buchmueller |
| Año | 2002 |
| Volumen | 40 |
| Número | 5 |
| Páginas | 362-374 |
| Fecha de publicación | 2002-05-01 |
| Peer Reviewed | Sí |
| Open Access | No |
| Tipo | ARTICLE |
| Revista | Medical Care (JOURNAL) |
| Identificadores de la revista | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Editorial | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/00005650-200205000-00002 |
| PMID | 11961471 |
| OpenAlex | W2325838624 |
| Idioma | EN |
| Citas recibidas | 6 |
| Referencias citadas | 37 |
BACKGROUND: With the growth in enrollment of Medicare patients in HMOs the effectiveness of care received by Medicare/HMO patients continues to be of concern. By considering the relationship of insurance to stage at diagnosis, this study inquires whether HMOs emphasize early diagnosis of colorectal cancer to a greater extent than FFS plans, if particular HMO types (group/nongroup models) are more successful in doing so, and how this pertains to survival. METHODS: Data for 1329 Medicare patients with colorectal cancer, diagnosed 1987 to 1993, and residing in northern California, were acquired from a population-based cancer registry. Insurance included two types of Medicare HMOs (group and nongroup model) and three fee-for-service (FFS) categories: Medicare with private supplement, Medicare/Medicaid, and Medicare only. The relationships of insurance to AJCC stage at diagnosis and of insurance to survival following diagnosis were examined, respectively, with logistic regression models and survival analysis (controlling for age, ethnicity, tumor location, educational level, sex, and hospital type). RESULTS: Likelihood of early stage colorectal cancer was greater for Medicare patients in nongroup model HMOs or having private FFS supplements than for those in group model HMOs, Medicare/Medicaid, or Medicare alone. All-cause and colorectal cancer mortality did not differ significantly among Medicare patients with group model HMO, nongroup model HMO and private FFS supplements. Medicare/Medicaid patients experienced significantly greater all-cause mortality than private FFS patients. CONCLUSIONS: Differences within this study population in early stage diagnosis of colorectal cancer and breast cancer, respectively, by type of Medicare supplemental insurance may be attributable to which preventive screening measures are included in health plan report cards
Cancer · Cancer registry · Colorectal cancer · Environmental health · Fee-for-service · Health care · Logistic regression · Medicaid · Population · Stage (stratigraphy) · Demography · Global Cancer Incidence and Screening · Healthcare Policy and Management · Internal Medicine · Medicine · Oncology · Primary Care and Health Outcomes
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes
Cancer of the Colorectum in Maine, 1995‐1998
Factors Associated With Colorectal Cancer Screening Among the US Urban Japanese Population
Costs and Survival of Patients With Colorectal Cancer in a Health Maintenance Organization and a Preferred Provider Organization
Comparison of Cancer Diagnosis and Treatment in Medicare Fee-for-Service and Managed Care Plans
Do HMO Market Level Factors Lead to Racial/Ethnic Disparities in Colorectal Cancer Screening
Measuring Social Class in US Public Health Research
Has the use of cervical, breast, and colorectal cancer screening increased in the United States
Colorectal Cancer Screening Participation
Stage of cancer at diagnosis for Medicare HMO and fee-for-service enrollees
The Relationship of HMOs, Health Insurance, and Delivery Systems to Breast Cancer Outcomes
Preventive Services Among Medicare Beneficiaries With Supplemental Coverage Versus HMO Enrollees, Medicaid Recipients, and Elders With No Additional Coverage
The Association Between Health Care Coverage and the Use of Cancer Screening Tests
| Obras citantes distintas | 6 |
|---|---|
| Citas por año | 0,27 |
| Intervalo de citas | 2004 - 2020 (17) |
| Velocidad de citación | historical |
| Altamente citado | No |
| Tipos de cita | Neutras: 6 |